FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/04/052115 [Registered on: 28/04/2023] Trial Registered Prospectively
Last Modified On: 06/06/2023
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to assess the efficacy and safety of Ayurvedic treatment Kneesol oil to compare with Dr Ortho oil and Diclofenac gel in Osteoarthritis patients. 
Scientific Title of Study   An open labelled, randomized single centric comparative clinical Study to evaluate the efficacy of the Ayurvedic Kneesol oil to claim substantiation in osteoarthritis compared with Dr Ortho oil and Diclofenac gel (1% w/w) or Diclofenac spray (1mg).  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
SP/HB/CT/23/12; Version 01 date: 16/03/2023   Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mahesh G 
Designation  Associate professor, Dept. of Othopedics 
Affiliation  Sapthagiri Institute of Medical Sciences and Research Centre 
Address  1st Floor, Dept. of Orthopaedics, No-15, Chikkasandra, Hesaraghatta Main Road.

Bangalore
KARNATAKA
560090
India 
Phone  9964428994  
Fax    
Email  drmaheshg85@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Baburao Vikram 
Designation  Director 
Affiliation  Pharexcel Consulting Private Limited 
Address  15093, 9th Floor, Tata New Haven, Seshagirirao Palya Village, Dasanpura Hobli, Near The Golden Palms Hotel & Spa Bengaluru North Taluka, Karnataka PIN: 562123

Bangalore
KARNATAKA
562123
India 
Phone  9878551428  
Fax    
Email  info@pharexcelconsulting.com  
 
Details of Contact Person
Public Query
 
Name  Gagan Goswami 
Designation  Director 
Affiliation  Cyizen Pharma Solutions Private Limited 
Address  238, The Galleria hub, Near Pal RTO, Adajan, Surat, Gujarat- 395009

Surat
GUJARAT
395009
India 
Phone  9662545775  
Fax    
Email  gagan@cyizen.com  
 
Source of Monetary or Material Support  
Madhusudan Healthcare, Plot No. 180 to 189, Block No. 281 to 283, Laxminarayan Ind. Estate, Village-Baleshwar, Taluka- Palsana, Dist. Surat-394317, Gujarat, India 
 
Primary Sponsor  
Name  Madhusudan Healthcare  
Address  Plot No. 180 to 189, Block No. 281 to 283, Laxminarayan Ind. Estate, Village-Baleshwar, Taluka- Palsana, Dist. Surat-394317, Gujarat, India 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mahesh G  Sapthagiri Institute of Medical Sciences & Research Centre (SIMSRC)  No-15, Chikkasandra, Hesaraghatta Main Road, Bengaluru-560090
Bangalore
KARNATAKA 
9964428994

drmaheshg85@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sapthagiri Institute of Medical Sciences and Research Centre Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M179||Osteoarthritis of knee, unspecified. Ayurveda Condition: SANDHIGATAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Volini Pain relief GelVolini Gel contains active ingredients Menthol and Methyl Salicylate, as well as Diclofenac Diethylamine and Linseed oil. Dosage 2 times daily for 3 months, topical application
2Intervention ArmDrugClassical(1) Medicine Name: Kneesol Oil, Reference: Herbal, Route: Topical, Dosage Form: Dravaka, Dose: 3(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: -
3Comparator ArmDrugClassical(1) Medicine Name: Dr Orthofit Oil, Reference: Herbal, Route: Topical, Dosage Form: Dravaka, Dose: 3(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.History of less than 30 min of morning sickness.
2. Clinical signs and symptoms corresponding to hip and/or knee
osteoarthritis for the previous three months.
3. Radiologically diagnosed osteoarthritis.
4. Subjects should have significant arthritic pain (Screening
WOMAC score between 10-40 or Visual Analogue Scale score
(VAS) between 4 to 9.
5. ESR < 40 mm/hr.
6. Willingness to sign the informed consent, follow the protocol and
participate in clinical trial voluntarily.
 
 
ExclusionCriteria 
Details  1.Seriously overweight, defined as body mass index of >35
2. post-surgical pain patients
3. Alcohol or drug abuse during the last three years
4. Patients incapacitated or bound to wheel chair or bed and unable
to carry out self-care activities.
5. Patients administering any herbal or topical herbal pain relief
agents.
6. The patients with current or recent corticosteroid treatment; or
ongoing treatment with anticoagulants, hydantoin, lithium,
steroids, methotrexate and colchicines or concurrent pain
relieving medication such as antipyretics, analgesics,
tranquilizers, hypnotic, excessive alcohol, NSAIDs.
7. History of active peptic ulcer, severe renal, hepatic or
hemopoietic disease or severe cardiac insufficiency or undergoing
coronary artery bypass graft (CABG) surgery.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. A decrease in WOMAC osteoarthritic index and
2. A decrease in the VAS scores.
 
12 weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
1. To assess the change in the biochemical parameters (CRP, CTX-1, ESR, LFT).
2. To assess the change in the digitalized X ray for the gap between femur and tibia to be measured at three points for cartilage damage and recovery.
 
12 weeks 
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   29/04/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Osteoarthritis (OA) is the most common form of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage that cushions the ends of the bones wears down over time. Although osteoarthritis can damage any joint, the disorder most commonly affects joints in your hands, knees, hips and spine.

Osteoarthritis symptoms can usually be managed, although the damage to joints can’t be reversed. Staying active, maintaining a healthy weight and receiving certain treatments might slow progression of the disease and help improve pain and joint function 1.

Kneesol Oil is an advanced proprietary Ayurvedic medicine indicated for effective management of Pain & inflammation of knee and joints associated with Osteoarthritis. The Oil is rational combination of clinically reported potent anti-inflammatory & analgesic herbs formulated in a fixed oil by following traditional Ayurvedic processing methods. The ingredients of kneesol oil are Zinziger officicnale, Allium sativa, Trachyspermum ammi and Trigonella foenum-graceum. The phytochemical constituents like flavonoids, phenols, thymol and the active substances like selenium, allicin and organosulfur are responsible for suppressing or inhibiting the inflammatory pathways and thus decreasing the oxidative stress, thereby modulating the pain and inflammation caused by the osteoarthritic.
 
Close